Results 81 to 90 of about 459,821 (133)
Variants in NGLY1 lead to intellectual disability, myoclonus epilepsy, sensorimotor axonal polyneuropathy and mitochondrial dysfunction. [PDF]
NGLY1 encodes the enzyme N-glycanase that is involved in the degradation of glycoproteins as part of the endoplasmatic reticulum-associated degradation pathway.
Brandt, F. van den +57 more
core +1 more source
Dysregulated proteome and N‐glycoproteome in ALG1‐deficient fibroblasts
Abstract Asparagine‐linked glycosylation 1 protein is a β‐1,4‐mannosyltransferase, is encoded by the ALG1 gene, which catalyzes the first step of mannosylation in N‐glycosylation. Pathogenic variants in ALG1 cause a rare autosomal recessive disorder termed as ALG1‐CDG.
Rohit Budhraja +5 more
wiley +1 more source
Modern anti‐CD38 monoclonal antibodies daratumumab and isatuximab have been associated with impairment of CD34+ cell mobilisation but the mechanism was not elucidated so far. In this study, we investigated the effect of three different regimens (dara‐VCd, isa‐KRd and VTd) on CD34+ cells and the findings suggest that upregulated adhesion‐related ...
Ondrej Venglar +18 more
wiley +1 more source
N-Glycanase 1 deficiency modeled in drosophila melanogaster
honors thesisSchool of Biological SciencesBiologyClement ChowNGLY1 deficiency is a rare genetic metabolic disorder with ~ 100 reported individuals. The disorder is the only known disorder of deglycosylation and causes an inability to deglycoslate a ...
Berman, Alexys
core
Discovering the Hidden Power of NGLY1: Orchestrating Immune Cell Functions and Autoimmune Diseases
The enzyme N-glycanase 1 (NGLY1) regulates autophagic processes and endoplasmic reticulum (ER)-associated proteasomal degradation by de-N-glycosylation of misfolded glycoproteins.
Christina B. Brunner +6 more
doaj +1 more source
Mapping Genetic Interactions for Rare Disease-Associated Genes [PDF]
Over 7,000 rare diseases have been identified in the human population that, in aggregate, affect over 400 million people worldwide. The majority of rare diseases that have been identified are genetic in origin.
Kantautas, Kristin
core +1 more source
Abstracts submitted to the ‘EACR 2026 Congress: Innovative Cancer Science’, from 08–11 June 2026 and accepted by the Congress Organising Committee are published in this Supplement of Molecular Oncology, an affiliated journal of the European Association for Cancer Research (EACR).
wiley +1 more source
An in vivo small molecule screen to identify therapeutics for NGLY1 deficiency
Presentation of poster 1993A at TAGC 2020 Online. Files include a PDF of the poster (TAGC_2020_Poster_Hope_Final.pdf)
Hope, Kevin A. +2 more
openaire +1 more source
NGLY1 mutation causes neuromotor impairment, intellectual disability, and neuropathy
N-glycanase 1 (NGLY1) is a conserved enzyme that is responsible for the deglycosylation of misfolded N-glycosylated proteins in the cytoplasm prior to their proteasome-mediated degradation.
Dolen, Duygu +16 more
core +1 more source

